What departments does CANbridge Pharmaceuticals Inc. have?

CANbridge Pharmaceuticals Inc. has employees across 8 departments including Business Development, Operations, Research, Engineering, Finance.

What is the largest department at CANbridge Pharmaceuticals Inc.?

The largest department at CANbridge Pharmaceuticals Inc. is Business Development with 2 employees.

Where are CANbridge Pharmaceuticals Inc. employees located globally?

CANbridge Pharmaceuticals Inc. has employees across 3 continents and 5 countries including China, India, United States Of America, Taiwan, Hong Kong.

How has CANbridge Pharmaceuticals Inc.'s team size changed over time?

CANbridge Pharmaceuticals Inc.'s team has decreased from approximately 30 to 27 employees based on available data.

CANbridge Pharmaceuticals Inc. Employee Directory

Q: Who are CANbridge Pharmaceuticals Inc.'s key employees and leadership?

CANbridge Pharmaceuticals Inc.'s key employees include: Chairman, President And Ceo: J. X., Chief Executive Officer: B. W., Chief Commercial Officer (cco): M. C., Vice President - Head Of Global Research: J. W., Vice President Of Business Development And Portfolio Management: D. L..

Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees

CANbridge Pharmaceuticals Inc. is a pharmaceutical manufacturing company headquartered in Burlington, Massachusetts, employing 11-50 people. It positions itself as China-focused and has been recognized as a leader in orphan diseases in China, aiming to accelerate development and commercialization of specialty products for rare diseases and targeted cancers where needs are underserved in the region. The company maintains a global partnership with WuXi Biologics to develop and commercialize therapeutics for rare genetic diseases. In Greater China, CANbridge has exclusive rights to commercialize Hunterase, an enzyme replacement therapy for Hunter syndrome, and exclusive rights to develop and commercialize Puma Biotechnology's NERLYNX (neratinib), as well as rights to other novel candidates. Recent activity includes the 2024 launches of Hunterase and Livmarli in China, and a 2025 strategic partnership and investment from Baheal to strengthen commercialization of rare disease products.

CANbridge Pharmaceuticals Inc. Global Highlights

Asia
33

China
32
India
1

North America
13

United States Of America
13

CANbridge Pharmaceuticals Inc.'s Leadership

B. W.
Chief Executive Officer
Mobile Phone
Email
M. C.
Chief Commercial Officer (cco)
Mobile Phone
Email
J. W.
Vice President - Head Of Global Research
Mobile Phone
Email
D. L.
Vice President Of Business Development And Portfolio Management
Mobile Phone
Email
K. P.
Head Of Operations And Integrations, Global Research
Mobile Phone
Email
J. X.
Chairman, President And Ceo
Mobile Phone
Email
Y. E. M.
Vp, Business Development And External Innovation
Mobile Phone
Email
P. L.
Senior Vp, Clinical Development & Operations
Mobile Phone
Email

CANbridge Pharmaceuticals Inc. Employee Metrics

100%

50%

0%

2026

2025

Biotechnology
Administrative
Business
Finance
Branding
Other

Contact profiles from CANbridge Pharmaceuticals Inc.

Name

Title

Contact Info

Location

Last Update

J. W.
Qa Director
Mobile Phone
Email
ChinaZhejiang
Jan 12, 2026
S. X.
Director Of Investor Relations
Mobile Phone
Email
Hong KongHong Kong
Jun 25, 2026
A. C.
Director Of Commercial Hk
Mobile Phone
Email
Hong KongHong Kong
Apr 01, 2026
C. S.
Clinical Development And Medical Affairs Director, Pv Director
Mobile Phone
Email
ChinaShanghai
Jun 01, 2026
J. C.
Strategic Finance Director
Mobile Phone
Email
Hong KongHong Kong
Apr 01, 2026
Y. J. Z.
Associate Director Of Finance
Mobile Phone
Email
ChinaBeijing
Feb 24, 2024
F. B.
Talent Acquisition Manager
Mobile Phone
Email
ChinaShanghai
Jun 24, 2026
许.
Senior Lead
Mobile Phone
Email
ChinaBeijing
Jan 12, 2026
T. L.
Regional Sales Manager
Mobile Phone
Email
TaiwanTakao
Apr 17, 2026
R. G.
Board Member
Mobile Phone
Email
United StatesMassachusetts
May 28, 2026

Frequently Asked Questions

What is CANbridge Pharmaceuticals Inc. known for?

CANbridge Pharmaceuticals Inc. was founded in 2012 operates in the Pharmaceutical Manufacturing industry. The company's main headquarters is located in 4 Burlington Woods Drive Burlington, Massachusetts 01803 United States. Explore CANbridge Pharmaceuticals Inc.'s company overview page for more information.

What is CANbridge Pharmaceuticals Inc.'s most common email format?

CANbridge Pharmaceuticals Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more CANbridge Pharmaceuticals Inc. email formats with LeadIQ.

How many employees does CANbridge Pharmaceuticals Inc. have currently?

CANbridge Pharmaceuticals Inc. has approximately 49 employees as of June 2026. These team members are located across 2 continents, including AsiaNorth America.

Who are CANbridge Pharmaceuticals Inc.'s key employees and leadership?

As of June 2026, CANbridge Pharmaceuticals Inc.'s key employees include:

Chief Executive Officer: B. W.
Chief Commercial Officer (cco): M. C.
Vice President - Head Of Global Research: J. W.
Vice President Of Business Development And Portfolio Management: D. L.
Head Of Operations And Integrations, Global Research: K. P.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

CANbridge Pharmaceuticals Inc. Employee Directory

Find CANbridge Pharmaceuticals Inc. employees' phone numbers or email addresses

Name search is limited — try advanced search instead